Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 07 - 29 save search
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ATI Physical Therapy (ATIP) on Behalf of Investors
Published: 2021-07-29 (Crawled : 23:00) - prnewswire.com
ATIP | News | $4.0601 0.25% 0.0% 980
|
Manufacturing
|
| O: -1.93%
H: 0.0%
C: 0.0%
therapy
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of ATI Physical Therapy (ATIP) on Behalf of Investors
Published: 2021-07-29 (Crawled : 23:00) - prnewswire.com
ATIP | News | $4.0601 0.25% 0.0% 980
|
Manufacturing
|
| O: -1.93%
H: 0.0%
C: 0.0%
therapy
Global $57.4 Billion Cell And Gene Therapy Manufacturing Market to 2028 - Rising Pressure on Drug Developers/Manufacturers to Meet the Growing Market Demand
Published: 2021-07-29 (Crawled : 22:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
gene therapy therapy growing drug gene therapies
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -1.17%
ARWR | $23.29 -2.06% -2.13% 810K
|
Health Technology
|
| O: 1.95%
H: 1.82%
C: -1.98%
disease liver disease treatment fda therapy breakthrough therapy liver designation
bluebird bio and National Resilience Ink Cell Therapy Strategic Alliance
Published: 2021-07-29 (Crawled : 18:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
therapy
Biologics Market Size to Reach USD 477.15 Billion in 2027 | Rapid Advancements in Molecular Therapy and Cell-Based Biologics, Increasing Incidence of Chronic Diseases, are Some Key Factors Driving Industry Growth, says Emergen Research
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
NVO | News | $126.16 -1.93% -2.24% 3M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
disease therapy molecular growth research merge
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.